Results 261 to 270 of about 125,967 (307)

MENOPAUSE AND HORMONE REPLACEMENT THERAPY

Medical Clinics of North America, 1998
Menopause is a normal part of life of most women and can be made easier with appropriate information about the events that occur. For those women who desire help for bothersome menopausal symptoms, effective therapy can be offered. The use of HRT for prevention is more complex.
openaire   +2 more sources

Hormone replacement therapy and hypertension

Current Opinion in Nephrology and Hypertension, 2002
Hypertension, particularly systolic hypertension, affects postmenopausal women and is an important risk factor for cardiovascular disease in this group. In the last year, several papers have better defined the mechanisms by which hormone replacement therapy influences blood pressure in postmenopausal women, including effects on nitric oxide ...
Veronica, Franco, Suzanne, Oparil
openaire   +2 more sources

The hormone replacement therapy controversy

Archives of Women's Mental Health, 2002
The issue of hormone replacement treatment for menopausal symptoms, osteoporosis, various cardiac problems, and other disorders has received a great deal of attention. Recent data concerning the benefits and risks have changed ideas about indications and contra-indications.
M T, Notman, C, Nadelson
openaire   +2 more sources

Individual hormone replacement therapy

Maturitas, 1996
Although hormone replacement therapy is widely used in western countries, compliance is not very good; only a minor proportion of women starting the treatment continue it for over 5 years. However, long-term treatment is essential for primary prevention of cardiovascular diseases and osteoporosis.
R J, Tuimala, T, Vihtamäki
openaire   +2 more sources

[Indications for hormone replacement therapy].

Minerva ginecologica, 2003
The purpose of the present study is to evaluate indications and contraindications, advisability and compliance of hormone replacement therapy (HRT) in women in the climacteric who, owing to the cessation of ovarian activity, face loss of the state of present and future wellbeing.A series of 602 women who have attended the Menopause Centre of the II ...
MAININI G, FESTA B, FESTA G, MESSALLI, Enrico Michelino, RAGUCCI A.   +4 more
openaire   +2 more sources

Hormone replacement therapy and longevity

Andrologia, 2015
To assess whether hormone replacement therapy influences longevity, an analysis was made of published life tables allowing for the calculation of the relative benefit of hormone replacement therapy on longevity in men with late onset hypogonadism and in post-menopausal women. It was found that testosterone replacement therapy of men suffering from late
openaire   +2 more sources

Hormone replacement therapy in hypopituitarism

Expert Opinion on Pharmacotherapy, 2004
Hypopituitarism is a disease complex characterised by varying pituitary hormonal deficiencies. The causes and manifestations of hypopituitarism are diverse, the most common being the presence of or treatment of a pituitary adenoma. Pressure effects from the tumour itself on normal pituitary tissue, together with the effects of surgical resection ...
openaire   +2 more sources

Hormone replacement therapy and the endometrium

Menopause International, 2009
The life-expectancy for women has increased significantly in the 20th century, although the time of onset of menopause has not. Almost a third of a woman's life is now postmenopausal and therefore many postmenopausal women consider using hormone replacement therapy (HRT) to improve their quality of life.
Daayana, S., Holland, C. M.
openaire   +3 more sources

Hormone replacement therapy and osteoporosis

Maturitas, 1996
Restoration of the osteoporotic skeleton is difficult. Factors that may aggravate the bone loss or increase the risk of fractures should be eliminated. The physician may then decide whether the patient is a candidate for one of the treatments which either stop further bone loss or increase the bone mass.
openaire   +2 more sources

Compliance with hormonal replacement therapy

Maturitas, 1991
One hundred post-menopausal women given HRT were reviewed 12 months after their first visit to determine their compliance with treatment. Sixty-one percent continued to take the therapy while 27% ceased. Most often the reason for ceasing HRT was return of bleeding but a number of women expressed fear of developing cancer or other long term ...
B G, Wren, L, Brown
openaire   +2 more sources